Rifaximin resistance in Escherichia coli associated with inflammatory bowel disease correlates with prior rifaximin use, mutations in rpoB, and activity of Phe-Arg-β-naphthylamide-inhibitable efflux pumps (Q42952867)
Jump to navigation
Jump to search
scientific article published on 26 November 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rifaximin resistance in Escherichia coli associated with inflammatory bowel disease correlates with prior rifaximin use, mutations in rpoB, and activity of Phe-Arg-β-naphthylamide-inhibitable efflux pumps |
scientific article published on 26 November 2012 |
Statements
1 reference
Rifaximin resistance in Escherichia coli associated with inflammatory bowel disease correlates with prior rifaximin use, mutations in rpoB, and activity of Phe-Arg-β-naphthylamide-inhibitable efflux pumps (English)
1 reference
1 reference
Josee Harel
1 reference
Vishesh Kothary
1 reference
Ellen J Scherl
1 reference
Zhi-Dong Jiang
1 reference
Herbert L Dupont
1 reference
Kenneth W Simpson
1 reference
Belgin Dogan
1 reference
26 November 2012
1 reference
1 reference
57
1 reference
811-817
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference